Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment ... as Novartis' Revolade (eltrombopag) or Amgen's Nplate (romiplostim). The drug has been available ...
and Amgen’s injectable Nplate (romiplostim) in the ITP indication. Doptelet is claimed to have a cleaner clinical profile compared to Promacta, lacking the dietary restrictions, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback